(Q40315007)

19 September 2017

Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer (English)

1 reference

19 September 2017

1 reference

Naruishi K

1

1 reference

19 September 2017

Timme TL

2

1 reference

19 September 2017

Kusaka N

3

1 reference

19 September 2017

Fujita T

4

1 reference

19 September 2017

Yang G

5

1 reference

19 September 2017

Goltsov A

6

1 reference

19 September 2017

Satoh T

7

1 reference

19 September 2017

Ji X

8

1 reference

19 September 2017

Tian W

9

1 reference

19 September 2017

Abdelfattah E

10

1 reference

19 September 2017

Men T

11

1 reference

19 September 2017

Watanabe M

12

1 reference

19 September 2017

Tabata K

13

1 reference

19 September 2017

Thompson TC

14

1 reference

19 September 2017

17 February 2006

1 reference

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

658-663

1 reference

19 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700919

19 September 2017

0 references

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Therapeutic targets for metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Cancer vaccines: between the idea and the reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Genetic, cellular and immune approaches to disease therapy: past and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Current developments of immunotherapy in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Demonstration of a rational strategy for human prostate cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

GM-CSF-based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

mRTVP-1, a novel p53 target gene with proapoptotic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

The human glioma pathogenesis-related protein is structurally related to plant pathogenesis-related proteins and its gene is expressed specifically in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

RTVP-1, a novel human gene with sequence similarity to genes of diverse species, is expressed in tumor cell lines of glial but not neuronal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Current developments in cancer vaccines and cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

Immunotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

inferred from DOI database lookup

7 January 2021

based on heuristic

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700919

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700919

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference